Wilson Mark Andrew, Chief Legal Officer of Nektar Therapeutics ($NKTR), sold shares on the open market three times in the last year, totaling nearly $59,000. His most recent sale occurred on November 25, 2025. These sales rank him 10,217th among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across about 6.4 transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 6, 2026 | Septerna, Inc. | $SEPN | Wilson Mark Andrew | Chief Legal Officer | A | Stock Option (Right to Buy) | 165000 | $0.00 | 165,000.0000 | 45,602,099 | 9999.99% | 0.36% |
| Nov. 25, 2025 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 630 | $54.28 | 21,585.0000 | 18,946,559 | 2.84% | 0.00% |
| Nov. 21, 2025 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | A | Common Stock | 1903 | $0.00 | 22,215.0000 | 18,946,559 | 9.37% | 0.01% |
| Nov. 21, 2025 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | A | Stock Option | 3400 | $0.00 | 3,400.0000 | 18,946,559 | 9999.99% | 0.02% |
| Aug. 19, 2025 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 676 | $26.59 | 20,312.0000 | 205,661,000 | 3.22% | 0.00% |
| Aug. 19, 2025 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | A | Stock Option | 21666 | $0.00 | 21,666.0000 | 205,661,000 | 9999.99% | 0.01% |
| May 19, 2025 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 9996 | $0.67 | 314,296.0000 | 205,661,000 | 3.08% | 0.00% |
| Feb. 19, 2025 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 11040 | $1.01 | 324,292.0000 | 205,661,000 | 3.29% | 0.01% |
| Dec. 23, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 33402 | $0.90 | 351,892.0000 | 13,949,851 | 8.67% | 0.24% |
| Dec. 24, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 16560 | $0.89 | 335,332.0000 | 13,949,851 | 4.71% | 0.12% |
| Dec. 13, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | A | Common Stock | 165938 | $0.00 | 385,294.0000 | 13,949,851 | 75.65% | 1.19% |
| Dec. 13, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | A | Stock Option | 331875 | $0.00 | 331,875.0000 | 13,949,851 | 9999.99% | 2.38% |
| Dec. 13, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | A | Stock Option | 325000 | $0.00 | 325,000.0000 | 13,949,851 | 9999.99% | 2.33% |
| Nov. 19, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 6407 | $1.01 | 218,856.0000 | 13,949,851 | 2.84% | 0.05% |
| Aug. 19, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 5651 | $1.28 | 225,263.0000 | 190,001,000 | 2.45% | 0.00% |
| May 17, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 6260 | $1.75 | 230,414.0000 | 190,001,000 | 2.64% | 0.00% |
| Feb. 20, 2024 | NEKTAR THERAPEUTICS | $NKTR | Wilson Mark Andrew | Chief Legal Officer | S | Common Stock | 7606 | $0.68 | 236,674.0000 | 190,001,000 | 3.11% | 0.00% |